Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04467801
Title Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Kansas Medical Center

lung non-small cell carcinoma



Docetaxel + Ipatasertib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST